Jortan is developing a novel approach to the treatment of Type-2 diabetes.
COARE Biotechnology is a research driven pharmaceutical company dedicated to developing novel therapeutic agents designed to treat solid tumor cancers.
Synereca Pharmaceuticals was created to address the growing problem of bacterial resistance to current antibiotics by developing orally active drugs that restore or increase the effectiveness of existing antibiotics.?
Mintiva develops products specially formulated for distinct topical applications.
Tetherex is focused on development of anti-PSGL-1 antibodies for the treatment of inflammatory and thrombotic diseases.
IMMY delivers diagnostics that can be performed without high-technology laboratory equipment or even electricity in general.